Navigation Links
Europe needs collective effort on System Biology, says ESF Task Force

Most of the diseases which plague humankind today are multifactorial: they are not simply the result of one mutation in one gene, producing one rogue protein that can no longer carry out its job. Diabetes and obesity, for instance, depend on many simultaneous genetic and environmental factors. Similarly, in biotechnology, processes cannot be optimised by simply changing one component of a complex process. It is the networks of interaction that Systems Biology, the study of how biological networking produces function at the level of the cell, organ and body, focuses on. The idea is that once we know which networks are fired in health, and misfired in disease, we will know how to fix the consequences of misfires by treating networks rather than just component molecules.

The situation is much like that of hooliganism in a soccer stadium, explains Professor Hans Westerhoff, who splits his time between the Manchester Centre for Integrative Systems Biology, Manchester, U.K. and the Netherlands Institute for Systems Biology in Amsterdam and is a member of the ESF Task Force. If one person or molecule incites a person who then incites the next, then the whole crowd will misbehave. To deal with this, one should moderate the network, by making sure the individuals are too far apart to interact.

Systems Biology requires the integration of precise mathematical and experimental approaches, in ways and to extents that are new to mainstream Biology and Medicine. Europe leads in most of these individual approaches, but Systems Biology of any particular disease requires the simultaneous study of all the links in huge networks, and the best scientists for each of the different links are in different European countries.

For Europe to take its lead in the research of Systems Biology, the continent needs to establish an interactive network itself, meaning that nations should not independently address their own parts of the grand challenge of Systems Biology. A paradigm shift is needed therefore, away from isolated, country-based, molecular biology and physiology, to extensive and intensive networks of excellent scientists across Europe.

The European Science Foundation (ESF) Task Force, comprising of nine experts in the field, has published a series of recommendations build on the ESF Forward Look report Systems Biology: a Grand Challenge for Europe. In their Strategic Guidance and Recommendations [] they set out a road map to establish a pioneering Systems Biology research programme in Europe. Based on the advice given by the Task Force the next steps will be to start actual discussions among the ESFs 75 Member Organisations, the Commission and other actors in the field, both public and private, on how to go forward.

The vision is that Europe will take the lead in making a blue cell a generic, model blueprint of a cell and then fill out the blueprint with information for a number of important diseases and biotechnological processes.

One prerequisite for this is new, much more quantitative, and biology-specific technology. A massive initiative is needed to develop the kinds of advanced technology that can look at networks in cells, clusters of cells, organs and bodies.

We cannot move forward in Systems Biology in Europe unless we have the technology to back up our vision, says Professor Rudolf Aebersold from the Institute of Molecular Systems Biology at ETH in Zurich, Switzerland, and a member of the ESF Task Force. We need new, powerful, user-friendly technologies not only to process and integrate large amounts of data, enhance data sharing and visualise models of biological systems, but also to collect that data in the first place.

Though the ultimate goal is applying Systems Biology to human health, to begin with it is likely that technology will also be developed and tested in smaller organisms and then scaled up to humans. Equally, the Task Force recommends that to begin with, particular topics on a common theme are chosen, such as cancer or obesity, and generic technology is produced that can then be applied to other areas.

To organise research in Europe, the Task Force recommends dividing funded research into two sub-themes: Systems Biotechnology and Multifactorial Diseases. These should be connected to, and incorporate, existing research programmes in Europe.

To achieve these goals, a massive workforce from many difference disciplines will be needed.

We need scientists that can understand both sides of the Systems Biology coin: biologists that can handle equations and physical scientists that know their way around in experimental biology, says Professor Westerhoff. The Task Force recommends that more support is given to existing Systems Biology training and exchange programmes so that scientists from other disciplines are attracted to our field.

The Europe-wide network will also need hubs; European reference laboratories allowing any researcher to conduct high quality research, even if their home institution cannot support it. These should also distribute standard experimental procedures, samples and datasets to ensure that everyone in the network is working in the same way. Similarly, Institutes of Advanced Studies should be established to host short-duration, focused programmes for researchers from across Europe.

The Task force has also suggested the ESF should support the overseeing of this network by continuing to support and host the establishment of a consortium of interested parties and support a European Systems Biology Office.


1. A task force of representatives from organisations investing in, or soon to invest, in Systems Biology should be established, supported by a European Systems Biology Office.

2. The task force will then:

  • Initiate, coordinate and fund a single GRand Action on Systems Biology (GRASB), consisting of activities working towards the integral Networks for Life project and become the worlds largest, best integrated, hence most effective Systems Biology programme.
  • Call for applications and expressions of interest in developing technology for and in carrying out world-leading Systems Biology research; a network of research on Systems Biotechnology; a network of research on multifactorial disease; a network of training activities; a network of European Reference Laboratories; and one or two Centres for Advanced Studies.
  • Organise workshops to ensure activities are kept up to date.
  • Develop a programme for GRASB, including funding mechanisms.
  • Define ways of disseminating strategies for all GRASB activities.


Contact: Thomas Lau
European Science Foundation

Related biology news :

1. Biologists discover why 10% of Europeans are safe from HIV
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Oldest cranial, dental and postcranial fossils of early modern European humans confirmed
4. Virulizin granted orphan drug status in Europe
5. European Commission funds EBI to do new research on synergies between bioinformatics and medical informatics
6. Earliest European Farmers Left Little Genetic Mark On Modern Europe
7. Do the Europeans turn ill sitting up so late?
8. Scientists identify 36 genes, 100 neuropeptides in honey bee brains
9. First-time analysis reveals millions of Europeans left at risk from influenza
10. Fragile US vaccine system needs improvement despite dramatic gains in health over past century
11. Rehydrate -- your RNA needs it
Post Your Comments:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, ... in the development and sale of broadly enabling, pressure ... life sciences industry, today announced it has received gross ... $5 million Private Placement (the "Offering"), increasing the total ...  One or more additional closings are expected in the ...
(Date:11/12/2015)... --  Growing need for low-cost, easy to use, ... the way for use of biochemical sensors for ... clinical, agricultural, environmental, food and defense applications. Presently, ... applications, however, their adoption is increasing in agricultural, ... on improving product quality and growing need to ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  HUYA Bioscience International, the ... pharmaceutical innovations, today announced it has signed ... Fund (KDDF) to foster collaboration between KDDF and HUYA ... commercialization of healthcare products for the global market. ... important source of new innovative preclinical and clinical stage ...
(Date:11/30/2015)... Florida and MAGDEBURG, Germany , ... of NeuroRehabilitation (ECNR) in Vienna, Austria ... 3rd European Congress of NeuroRehabilitation (ECNR) in ... --> NovaVision, a wholly owned subsidiary of Vycor ... European version of its Internet-delivered NovaVision Therapy Suite at the ...
(Date:11/30/2015)... Israel , Nov. 30, 2015 BrainStorm ... developer of adult stem cell technologies for neurodegenerative diseases, today ... been awarded an additional grant of approximately $735,000 from ... This grant, the second this year, brings the total awarded ... million (approximately NIS7 million).  ...
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased to ... presentations offered in symposia, oral sessions, workshops, awards, and posters. The core ... of applications such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, ...
Breaking Biology Technology: